Shu Zhang Selected Research

6-methyl-1,3,8-trichlorodibenzofuran

1/2012	Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
9/2009	The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shu Zhang Research Topics

Disease

175	Neoplasms (Cancer) 10/2022 - 12/2003
54	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2007
50	Neoplasm Metastasis (Metastasis) 10/2022 - 02/2005
40	Infections 06/2022 - 08/2005
37	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2005
36	Heart Failure 01/2022 - 03/2006
34	Atrial Fibrillation 01/2022 - 10/2004
33	Inflammation (Inflammations) 08/2022 - 07/2007
26	Ventricular Tachycardia 01/2022 - 02/2004
24	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2005
21	Fibrosis (Cirrhosis) 10/2021 - 09/2004
20	Carcinogenesis 01/2022 - 02/2007
16	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 06/2008
16	Tachycardia (Tachyarrhythmias) 01/2020 - 10/2003
14	Esophageal Squamous Cell Carcinoma 01/2022 - 09/2013
14	Lymphatic Metastasis 06/2021 - 09/2013
14	Stroke (Strokes) 04/2021 - 12/2009
14	Wounds and Injuries (Trauma) 01/2020 - 01/2003
13	Tuberculosis (Tuberculoses) 01/2021 - 11/2008
13	Cardiac Arrhythmias (Arrythmia) 01/2021 - 10/2007
12	Carcinoma (Carcinomatosis) 06/2019 - 02/2005
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2008
10	Obesity 01/2022 - 06/2008
10	Death (Near-Death Experience) 01/2021 - 01/2015
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 09/2004
10	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2020 - 10/2007
10	Colorectal Neoplasms (Colorectal Cancer) 02/2019 - 01/2013
9	Type 2 Diabetes Mellitus (MODY) 04/2022 - 01/2015
9	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 09/2008
9	Asthma (Bronchial Asthma) 01/2022 - 06/2005
8	Lung Neoplasms (Lung Cancer) 06/2022 - 12/2013
8	Hemorrhage 01/2022 - 12/2012
8	Shock 01/2022 - 11/2016
8	COVID-19 01/2022 - 11/2020
8	Lung Injury 01/2021 - 01/2003
8	Cognitive Dysfunction 07/2020 - 01/2015
8	Liver Diseases (Liver Disease) 11/2019 - 09/2004
7	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 01/2018
7	Glioma (Gliomas) 05/2022 - 07/2017
7	Adenocarcinoma 01/2022 - 01/2005
7	Liver Neoplasms (Liver Cancer) 01/2022 - 12/2003
7	Hypertension (High Blood Pressure) 08/2021 - 01/2014
7	Bundle-Branch Block (Fascicular Block) 01/2020 - 03/2006
6	Melanoma (Melanoma, Malignant) 06/2022 - 01/2014
6	Pathologic Processes 06/2022 - 08/2017
6	Rectal Neoplasms (Rectal Cancer) 05/2022 - 01/2018
6	Ischemia 02/2022 - 04/2014
6	Diabetic Nephropathies (Diabetic Nephropathy) 02/2022 - 04/2016
6	Body Weight (Weight, Body) 01/2022 - 06/2008
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 09/2006
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 09/2009
6	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 10/2014
6	Osteoporosis 01/2022 - 10/2018
6	Insulin Resistance 01/2022 - 06/2008

Drug/Important Bio-Agent (IBA)

88	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2002
44	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2004
26	Biological ProductsIBA 04/2022 - 04/2005
23	Pharmaceutical PreparationsIBA 01/2022 - 12/2007
23	CytokinesIBA 10/2021 - 07/2006
19	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2008
17	EnzymesIBA 01/2022 - 07/2006
16	Messenger RNA (mRNA)IBA 04/2020 - 11/2010
15	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2009
15	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2010
15	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2010
14	Long Noncoding RNAIBA 01/2022 - 09/2016
12	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2016
10	AntigensIBA 03/2022 - 09/2004
10	Phosphotransferases (Kinase)IBA 01/2022 - 10/2013
10	HaptoglobinsIBA 11/2021 - 05/2011
9	InterferonsIBA 03/2022 - 11/2010
9	C-Reactive ProteinIBA 01/2022 - 09/2009
9	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 05/2006
9	LigandsIBA 01/2021 - 06/2011
9	Polysaccharides (Glycans)IBA 11/2019 - 05/2011
8	Indicators and Reagents (Reagents)IBA 11/2022 - 09/2004
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2008
7	baicaleinIBA 08/2022 - 12/2003
7	AntioxidantsIBA 01/2022 - 01/2012
7	Therapeutic UsesIBA 01/2022 - 06/2016
7	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 06/2008
7	LipidsIBA 01/2021 - 02/2011
7	Caspase 3 (Caspase-3)IBA 04/2020 - 01/2013
6	Monoclonal AntibodiesIBA 05/2022 - 01/2012
6	Insulin (Novolin)FDA Link 01/2022 - 06/2008
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2014
6	AnticoagulantsIBA 01/2022 - 10/2014

Therapy/Procedure

88	Therapeutics 10/2022 - 04/2006
39	Catheter Ablation 01/2022 - 10/2003
36	Cardiac Resynchronization Therapy 01/2022 - 03/2006
28	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 04/2006
18	Drug Therapy (Chemotherapy) 01/2022 - 05/2009
14	Defibrillators (Defibrillator) 01/2022 - 12/2007
8	Heart Transplantation (Grafting, Heart) 01/2022 - 05/2009
8	Radiotherapy 12/2021 - 04/2014
7	Immunotherapy 01/2022 - 11/2010
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 05/2017
7	Radiofrequency Ablation 01/2021 - 04/2007
6	Neoadjuvant Therapy 12/2022 - 01/2021
6	Aftercare (After-Treatment) 01/2022 - 04/2005